subsidiaries for the three- month period ended March 31, 2020. The Company would like to clarify on the operating results as follows: Revenue • For Q1/ 2020, total consolidated revenues advanced to Baht 424.91

“Company” or “we” or “our” or “us”) would like to inform management discussion and analysis for its results of operations from the consolidated financial statements for the nine months period ended September

” or “our” or “us”) would like to inform management discussion and analysis for its results of operations from the consolidated financial statements for the year ended December 31, 2018 as follows

the consolidated reviewed the 3rd quarter financial statements as of November 30, 2022 which were reviewed by Deloitte Touche Tohmatsu Jaiyos Audit Company Limited. The operating performance is

consolidated revenues have increased to Baht 360.4 and Baht 797.3 million, a 0.8% and 11.8% growth over same period of last year with details as the followings: - The revenues for 2nd-quarter and 6-month

“Company” or “we” or “our” or “us”) would like to inform management discussion and analysis for its results of operations from the consolidated financial statements for the three months period ended March 31

change of scoring criteria effective this year despite an increase of average number of registered patients to 176,554 from 164,812 person yoy. Operation : Consolidated Profit & Loss Statement 3Q 3Q % 9

3,842 5,227 339 20 137 -86 195 102 134% -34% 9% 91% 57% 43% 1Q2020 1Q2019 4Q2019 253 215 239 Operating Performance Exhibit 1: Consolidated Company’s Performance comparison of 1Q2020 vs. 1Q2019 vs. 4Q2019

selling price escalated in tandem with upward CPO price compared to prior year. In 2Q2020, the Company had total sales revenue of THB 3,931 million, rose by THB 641 million or 19% compared to 2Q2019, even

: pato1@cscoms.com August 11, 2017 President The Stock Exchange of Thailand The consolidated financial statement of Pato Chemical Industry Plc. and its subsidiary for Q2 ended June 30, 2017 operational